Arado, Jessa Mae .
HRN: 11-88-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2024
CEFUROXIME 750MG (VIAL)
10/23/2024
10/30/2024
IV
1.5g
Q8 X 7 Days
S/p Repeat LSTCS With BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes